Global Medical Foams Market Trajectory & Analytics Report 2020-2027 with Short-term Impacts of COVID-19 on Production & Procurement - ResearchAndMarkets.com
Global Medical Foams Market to Reach $27.7 Billion by 2027
Amid the COVID-19 crisis, the global market for Medical Foams estimated at US$17.3 Billion in the year 2020, is projected to reach a revised size of US$27.7 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027.
Polyurethane, one of the segments analyzed in the report, is projected to record a 8.1% CAGR and reach US$9.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polystyrene segment is readjusted to a revised 7.1% CAGR for the next 7-year period.
The U. S. Market is Estimated at $4.7 Billion, While China is Forecast to Grow at 10.7% CAGR
The Medical Foams market in the U. S. is estimated at US$4.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2027 trailing a CAGR of 10.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
Polyolefin Segment to Record 6.4% CAGR
In the global Polyolefin segment, USA, Canada, Japan, China and Europe will drive the 5.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.3 Billion in the year 2020 will reach a projected size of US$3.5 Billion by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.8 Billion by the year 2027, while Latin America will expand at a 7.7% CAGR through the analysis period.
The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others:
3M Company
Absolute Packaging
Allied Aerofoam Products, LLC
Amatech, Inc.
Amcon American Converters, Inc.
American Excelsior Company
American Flexible Products, Inc.
American Foam Products
American Foam Technologies, Inc.
Armacell GmbH
Avery Dennison Corporation
BASF SE
Bayer AG
Clark Foam Products Corporation
DowDuPont
Flextech, Inc.
Foam Products, Inc.
Foam Sciences
Foam Techniques Ltd.
Foamcraft, Inc.
FoamPartner (Fritz Nauer AG)
Foamtec Medical
Future Foam, Inc.
FXI - Foamex Innovations
General Plastics Manufacturing Co., Inc.
Grand Rapids Foam Technologies
Heubach Corporation
Huntsman Corporation
INOAC Corporation
Intec Foams Ltd.
Parafix Tapes & Conversions Ltd.
Polyformes Ltd.
Recticel NV
Reilly Foam Corporation
Rempac Foam, LLC
Rogers Corporation
Rogers Foam Corporation
Rynel, Inc.
Sekisui Chemical Co., Ltd.
Technical Foam Services
The Woodbridge Group
Trelleborg AB
UFP Technologies, Inc.
Value Foam, Inc.
Vitacare Medical Products
Wisconsin Foam Products
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Polyurethane (Material Type) World Market by Region/Country in US$ Million: 2020 to 2027
Polyurethane (Material Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
Polyurethane (Material Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Polystyrene (Material Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
Polystyrene (Material Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
Polystyrene (Material Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Polyolefin (Material Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
Polyolefin (Material Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
Polyolefin (Material Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Polyvinyl Chloride (Material Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
Polyvinyl Chloride (Material Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
Polyvinyl Chloride (Material Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
Medical Packaging (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
Medical Packaging (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
Medical Packaging (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
Medical Devices & Components (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
Medical Devices & Components (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
Medical Devices & Components (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
Prosthetics & Wound Care (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
Prosthetics & Wound Care (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
Prosthetics & Wound Care (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA manufacturing facility. The 32,000-square-foot facility was...
Phillips is promoted to the newly created role of PresidentWorking alongside William Trainer, Founder and CEO, Phillips will drive strategic and operational initiatives to streamline production and increase vehicle sales across the Company's industry...
CureVac N.V. ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), will report financial results, and provide business updates for the...
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders, announced today...
BEYFORTUS® (nirsevimab) is the first long-acting antibody approved in Canada for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates and infants through their first RSV season.iBEYFORTUS® is also approved...
NioCorp Developments Ltd. ("NioCorp" or the "Company") plans to investigate the feasibility of recycling permanent rare earth magnets as part of NioCorp's proposed Elk Creek Critical Minerals Project (the "Elk Creek...